The Allergic Bronchopulmonary Aspergillosis (ABPA) Panel is a group of blood tests used to assess an exaggerated immune response to Aspergillus fungi in the lungs. It typically evaluates specific antibodies and other markers associated with ABPA. The panel is needed when ABPA is suspected, particularly in individuals with asthma or cystic fibrosis who develop worsening respiratory symptoms, recurrent lung problems, or unexplained pulmonary changes.
ABPA is an allergic reaction to Aspergillus, a type of fungus commonly found in the environment. It mainly affects the airways and can cause inflammation and mucus buildup.
Aspergillus is a group of fungi found widely in soil, dust, and decaying organic matter. Most people inhale its spores without developing illness.
Elevated total IgE may occur in ABPA, but it is not specific to the condition and can also be seen with allergies, parasitic infections, and other disorders.
It indicates sensitization to Aspergillus and may support the evaluation of ABPA when combined with symptoms, imaging, and other laboratory findings.
It may indicate an immune response to Aspergillus. However, it can occur in other situations and does not by itself confirm ABPA.
No. ABPA diagnosis generally requires a combination of clinical features, blood tests, and sometimes chest imaging. The exact diagnostic criteria may vary depending on the clinical setting.
OTP sent to your mobile number on whatsapp
Didn't recieved OTP Yet? Resend OTP
